Market Insights Health Medical Technology Medical Devices

Endoscopic Devices - United States

United States

In the United States, revenue in the Endoscopic Devices market market is projected to reach €9.64bn in 2024.
The revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 6.86%, leading to a market volume of €13.43bn by 2029.
In a global context, the majority of revenue will be generated the in the United States, amounting to €9.64bn in 2024.
The United States is witnessing a significant shift towards minimally invasive surgical procedures, driving demand for advanced endoscopic devices in the medical technology market.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Endoscopic Devices Market in the United States is experiencing moderate growth, influenced by advancements in technology, increasing demand for minimally invasive procedures, and a greater focus on early disease detection and diagnosis.

Customer preferences: Consumers are showing a growing preference for minimally invasive surgical options, influencing the demand for advanced endoscopic devices. This shift is driven by an increasing awareness of the benefits of quicker recovery times and reduced post-operative pain. Additionally, as the population ages, there is a heightened focus on early detection of diseases, prompting a rise in preventive care. Furthermore, the integration of telehealth services is reshaping patient interactions with healthcare providers, enhancing accessibility to endoscopic procedures and consultations.

Trends in the market: In the United States, the Endoscopic Devices Market is experiencing a surge in demand for innovative, minimally invasive surgical options, driven by patient preferences for reduced recovery times and lower post-operative discomfort. As the aging population increases, there is a greater emphasis on early disease detection, boosting the use of advanced endoscopic technologies for preventive care. Additionally, the integration of telehealth services is transforming patient-provider interactions, making endoscopic procedures more accessible. These trends hold significant implications for manufacturers and healthcare providers, necessitating investment in technology and training to meet evolving patient needs.

Local special circumstances: In the United States, the Endoscopic Devices Market is shaped by a complex interplay of regulatory frameworks, diverse demographics, and advanced healthcare infrastructure. Stringent FDA regulations ensure high safety standards, fostering trust in innovative technologies. The country's vast geographic expanse leads to disparities in healthcare access, prompting manufacturers to focus on scalable solutions for rural areas. Additionally, cultural attitudes towards preventive care and health awareness drive demand for endoscopic procedures, further influencing market growth and necessitating tailored marketing strategies.

Underlying macroeconomic factors: The Endoscopic Devices Market in the United States is significantly influenced by macroeconomic factors such as healthcare spending trends, economic growth, and demographic shifts. The increasing allocation of resources towards healthcare underpins the demand for advanced medical technologies, including endoscopic devices. National economic health, marked by GDP growth and employment rates, contributes to consumer spending on healthcare services. Moreover, fiscal policies that support medical research and development foster innovation. The rise in chronic diseases and an aging population further amplify the need for minimally invasive procedures, positioning endoscopic devices as critical tools in enhancing patient outcomes and optimizing healthcare delivery.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.